323 related articles for article (PubMed ID: 17254959)
1. Oncogene-induced senescence pathways weave an intricate tapestry.
Yaswen P; Campisi J
Cell; 2007 Jan; 128(2):233-4. PubMed ID: 17254959
[TBL] [Abstract][Full Text] [Related]
2. PRAK is essential for ras-induced senescence and tumor suppression.
Sun P; Yoshizuka N; New L; Moser BA; Li Y; Liao R; Xie C; Chen J; Deng Q; Yamout M; Dong MQ; Frangou CG; Yates JR; Wright PE; Han J
Cell; 2007 Jan; 128(2):295-308. PubMed ID: 17254968
[TBL] [Abstract][Full Text] [Related]
3. A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence.
Zheng H; Seit-Nebi A; Han X; Aslanian A; Tat J; Liao R; Yates JR; Sun P
Mol Cell; 2013 Jun; 50(5):699-710. PubMed ID: 23685072
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
Serrano M; Lin AW; McCurrach ME; Beach D; Lowe SW
Cell; 1997 Mar; 88(5):593-602. PubMed ID: 9054499
[TBL] [Abstract][Full Text] [Related]
5. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T; Schmidt ML; Donninger H; Clark GJ
Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
[TBL] [Abstract][Full Text] [Related]
6. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.
Mallette FA; Gaumont-Leclerc MF; Ferbeyre G
Genes Dev; 2007 Jan; 21(1):43-8. PubMed ID: 17210786
[TBL] [Abstract][Full Text] [Related]
7. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide metabolism, oncogene-induced senescence and cancer.
Aird KM; Zhang R
Cancer Lett; 2015 Jan; 356(2 Pt A):204-10. PubMed ID: 24486217
[TBL] [Abstract][Full Text] [Related]
9. Oncogene-induced senescence: a double edged sword in cancer.
Liu XL; Ding J; Meng LH
Acta Pharmacol Sin; 2018 Oct; 39(10):1553-1558. PubMed ID: 29620049
[TBL] [Abstract][Full Text] [Related]
10. Ing1 mediates p53 accumulation and chromatin modification in response to oncogenic stress.
Abad M; Menéndez C; Füchtbauer A; Serrano M; Füchtbauer EM; Palmero I
J Biol Chem; 2007 Oct; 282(42):31060-7. PubMed ID: 17693408
[TBL] [Abstract][Full Text] [Related]
11. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
13. DNAJB9 Inhibits p53-Dependent Oncogene-Induced Senescence and Induces Cell Transformation.
Lee HJ; Jung YJ; Lee S; Kim JI; Han JA
Mol Cells; 2020 Apr; 43(4):397-407. PubMed ID: 32264658
[No Abstract] [Full Text] [Related]
14. Identification of a DNA Damage-Induced Alternative Splicing Pathway That Regulates p53 and Cellular Senescence Markers.
Chen J; Crutchley J; Zhang D; Owzar K; Kastan MB
Cancer Discov; 2017 Jul; 7(7):766-781. PubMed ID: 28288992
[TBL] [Abstract][Full Text] [Related]
15. Activation of p53 by oncogenes.
Lowe SW
Endocr Relat Cancer; 1999 Mar; 6(1):45-8. PubMed ID: 10732786
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the LXCXE binding cleft of pRb facilitates transformation by ras in vitro but does not promote tumorigenesis in vivo.
Talluri S; Francis SM; Dick FA
PLoS One; 2013; 8(8):e72236. PubMed ID: 23936539
[TBL] [Abstract][Full Text] [Related]
17. Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice.
Nannenga B; Lu X; Dumble M; Van Maanen M; Nguyen TA; Sutton R; Kumar TR; Donehower LA
Mol Carcinog; 2006 Aug; 45(8):594-604. PubMed ID: 16652371
[TBL] [Abstract][Full Text] [Related]
18. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
Donninger H; Calvisi DF; Barnoud T; Clark J; Schmidt ML; Vos MD; Clark GJ
J Cell Biol; 2015 Mar; 208(6):777-89. PubMed ID: 25778922
[TBL] [Abstract][Full Text] [Related]
19. A new p53 target gene, RKIP, is essential for DNA damage-induced cellular senescence and suppression of ERK activation.
Lee SJ; Lee SH; Yoon MH; Park BJ
Neoplasia; 2013 Jul; 15(7):727-37. PubMed ID: 23814485
[TBL] [Abstract][Full Text] [Related]
20. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms.
Kwong J; Hong L; Liao R; Deng Q; Han J; Sun P
J Biol Chem; 2009 Apr; 284(17):11237-46. PubMed ID: 19251701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
